Dennis Watson to Genetic Therapy
This is a "connection" page, showing publications Dennis Watson has written about Genetic Therapy.
Connection Strength
0.443
-
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.
Score: 0.252
-
Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Mol Ther. 2006 Feb; 13(2):357-65.
Score: 0.054
-
ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005 Nov; 41(16):2462-78.
Score: 0.054
-
CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Res. 2003 May-Jun; 23(3A):2007-13.
Score: 0.046
-
The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer. Surgery. 2000 Aug; 128(2):353-60.
Score: 0.038